Publication | Closed Access
Economic Evaluations of Everolimus Versus Other Hormonal Therapies in the Treatment of HR+/HER2− Advanced Breast Cancer From a US Payer Perspective
27
Citations
40
References
2015
Year
Us Payer PerspectiveBreast OncologyOncologyHealth EconomicsCancer ManagementBreast CancerCancer TreatmentEconomic EvaluationsMedicineRadiation OncologyEndocrine-related CancerHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1